528 related articles for article (PubMed ID: 22639965)
1. Leucine-rich repeat kinase 2 disturbs mitochondrial dynamics via Dynamin-like protein.
Niu J; Yu M; Wang C; Xu Z
J Neurochem; 2012 Aug; 122(3):650-8. PubMed ID: 22639965
[TBL] [Abstract][Full Text] [Related]
2. LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1.
Wang X; Yan MH; Fujioka H; Liu J; Wilson-Delfosse A; Chen SG; Perry G; Casadesus G; Zhu X
Hum Mol Genet; 2012 May; 21(9):1931-44. PubMed ID: 22228096
[TBL] [Abstract][Full Text] [Related]
3. ULK1 and JNK are involved in mitophagy incurred by LRRK2 G2019S expression.
Zhu Y; Wang C; Yu M; Cui J; Liu L; Xu Z
Protein Cell; 2013 Sep; 4(9):711-21. PubMed ID: 27023913
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of excessive mitochondrial fission reduced aberrant autophagy and neuronal damage caused by LRRK2 G2019S mutation.
Su YC; Qi X
Hum Mol Genet; 2013 Nov; 22(22):4545-61. PubMed ID: 23813973
[TBL] [Abstract][Full Text] [Related]
5. Extracellular signal-regulated kinase is involved in alpha-synuclein-induced mitochondrial dynamic disorders by regulating dynamin-like protein 1.
Gui YX; Wang XY; Kang WY; Zhang YJ; Zhang Y; Zhou Y; Quinn TJ; Liu J; Chen SD
Neurobiol Aging; 2012 Dec; 33(12):2841-54. PubMed ID: 22445325
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of ERK-DLP1 signaling and mitochondrial division alleviates mitochondrial dysfunction in Alzheimer's disease cybrid cell.
Gan X; Huang S; Wu L; Wang Y; Hu G; Li G; Zhang H; Yu H; Swerdlow RH; Chen JX; Yan SS
Biochim Biophys Acta; 2014 Feb; 1842(2):220-31. PubMed ID: 24252614
[TBL] [Abstract][Full Text] [Related]
7. Parkinson's disease-associated DJ-1 mutations impair mitochondrial dynamics and cause mitochondrial dysfunction.
Wang X; Petrie TG; Liu Y; Liu J; Fujioka H; Zhu X
J Neurochem; 2012 Jun; 121(5):830-9. PubMed ID: 22428580
[TBL] [Abstract][Full Text] [Related]
8. Impaired balance of mitochondrial fission and fusion in Alzheimer's disease.
Wang X; Su B; Lee HG; Li X; Perry G; Smith MA; Zhu X
J Neurosci; 2009 Jul; 29(28):9090-103. PubMed ID: 19605646
[TBL] [Abstract][Full Text] [Related]
9. The LRRK2 inhibitor GSK2578215A induces protective autophagy in SH-SY5Y cells: involvement of Drp-1-mediated mitochondrial fission and mitochondrial-derived ROS signaling.
Saez-Atienzar S; Bonet-Ponce L; Blesa JR; Romero FJ; Murphy MP; Jordan J; Galindo MF
Cell Death Dis; 2014 Aug; 5(8):e1368. PubMed ID: 25118928
[TBL] [Abstract][Full Text] [Related]
10. Functional interaction of Parkinson's disease-associated LRRK2 with members of the dynamin GTPase superfamily.
Stafa K; Tsika E; Moser R; Musso A; Glauser L; Jones A; Biskup S; Xiong Y; Bandopadhyay R; Dawson VL; Dawson TM; Moore DJ
Hum Mol Genet; 2014 Apr; 23(8):2055-77. PubMed ID: 24282027
[TBL] [Abstract][Full Text] [Related]
11. Adenoviral-mediated expression of G2019S LRRK2 induces striatal pathology in a kinase-dependent manner in a rat model of Parkinson's disease.
Tsika E; Nguyen AP; Dusonchet J; Colin P; Schneider BL; Moore DJ
Neurobiol Dis; 2015 May; 77():49-61. PubMed ID: 25731749
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial Calcium Dysregulation Contributes to Dendrite Degeneration Mediated by PD/LBD-Associated LRRK2 Mutants.
Verma M; Callio J; Otero PA; Sekler I; Wills ZP; Chu CT
J Neurosci; 2017 Nov; 37(46):11151-11165. PubMed ID: 29038245
[TBL] [Abstract][Full Text] [Related]
13. LRRK2 enhances oxidative stress-induced neurotoxicity via its kinase activity.
Heo HY; Park JM; Kim CH; Han BS; Kim KS; Seol W
Exp Cell Res; 2010 Feb; 316(4):649-56. PubMed ID: 19769964
[TBL] [Abstract][Full Text] [Related]
14. G2019S leucine-rich repeat kinase 2 causes uncoupling protein-mediated mitochondrial depolarization.
Papkovskaia TD; Chau KY; Inesta-Vaquera F; Papkovsky DB; Healy DG; Nishio K; Staddon J; Duchen MR; Hardy J; Schapira AH; Cooper JM
Hum Mol Genet; 2012 Oct; 21(19):4201-13. PubMed ID: 22736029
[TBL] [Abstract][Full Text] [Related]
15. Leucine-rich repeat kinase 2 (LRRK2)/PARK8 possesses GTPase activity that is altered in familial Parkinson's disease R1441C/G mutants.
Li X; Tan YC; Poulose S; Olanow CW; Huang XY; Yue Z
J Neurochem; 2007 Oct; 103(1):238-47. PubMed ID: 17623048
[TBL] [Abstract][Full Text] [Related]
16. Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity.
West AB; Moore DJ; Choi C; Andrabi SA; Li X; Dikeman D; Biskup S; Zhang Z; Lim KL; Dawson VL; Dawson TM
Hum Mol Genet; 2007 Jan; 16(2):223-32. PubMed ID: 17200152
[TBL] [Abstract][Full Text] [Related]
17. Dopaminergic neurodegeneration induced by Parkinson's disease-linked G2019S LRRK2 is dependent on kinase and GTPase activity.
Nguyen APT; Tsika E; Kelly K; Levine N; Chen X; West AB; Boularand S; Barneoud P; Moore DJ
Proc Natl Acad Sci U S A; 2020 Jul; 117(29):17296-17307. PubMed ID: 32631998
[TBL] [Abstract][Full Text] [Related]
18. Mutations in LRRK2 increase phosphorylation of peroxiredoxin 3 exacerbating oxidative stress-induced neuronal death.
Angeles DC; Gan BH; Onstead L; Zhao Y; Lim KL; Dachsel J; Melrose H; Farrer M; Wszolek ZK; Dickson DW; Tan EK
Hum Mutat; 2011 Dec; 32(12):1390-7. PubMed ID: 21850687
[TBL] [Abstract][Full Text] [Related]
19. Parkinson's disease-associated mutant VPS35 causes mitochondrial dysfunction by recycling DLP1 complexes.
Wang W; Wang X; Fujioka H; Hoppel C; Whone AL; Caldwell MA; Cullen PJ; Liu J; Zhu X
Nat Med; 2016 Jan; 22(1):54-63. PubMed ID: 26618722
[TBL] [Abstract][Full Text] [Related]
20. GTPase activity and neuronal toxicity of Parkinson's disease-associated LRRK2 is regulated by ArfGAP1.
Stafa K; Trancikova A; Webber PJ; Glauser L; West AB; Moore DJ
PLoS Genet; 2012; 8(2):e1002526. PubMed ID: 22363216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
